Group items tagged

"From the perspective of the USTR, the TPP is not a threat to global health initiatives that rely on generics, but rather a blueprint for international norms that promote innovation in global health and elsewhere. However, amfAR's Senior Research Advisor, Brian Honermann, labels the USTR's outlook on HIV and the TPP as "inaccurate." He notes that the TPP contains "unprecedented intellectual property protections" around data exclusivity and the scope of patentability, both of which could make it harder to integrate new treatment options into large public sector programs that rely overwhelmingly on off-label drugs. "

" What really causes addiction - to everything from cocaine to smart-phones? And how can we overcome it? Johann Hari has seen our current methods fail firsthand, as he has watched loved ones struggle to manage their addictions. He started to wonder why we treat addicts the way we do - and if there might be a better way. As he shares in this deeply personal talk, his questions took him around the world, and unearthed some surprising and hopeful ways of thinking about an age-old problem. "